CBOE vs CPRX · P/E 24, rev $2.72B vs P/E 18, rev $491.7M
Cboe Global Markets Inc (CBOE) versus Catalyst Pharmaceuticals Inc (CPRX) — a side-by-side from cached financials, not a winner call.
Cboe Global Markets Inc (CBOE) is a financial data & stock exchanges company listed on US.
Catalyst Pharmaceuticals Inc (CPRX) is a biotechnology company listed on NASDAQ.
Latest reported CBOE revenue for 2026-06-30 was $2.72B. Net income was $738.8M. CBOE currently screens at market cap $29.50B and trailing P/E 24.1.
Latest reported CPRX revenue for 2024-12-31 was $491.7M. Net income was $163.9M. Revenue was up 23.5% from 2023-12-31 to 2024-12-31. CPRX currently screens at market cap $3.84B and trailing P/E 18.2.
CBOE currently screens at market cap $29.50B and trailing P/E 24.1. CPRX currently screens at market cap $3.84B and trailing P/E 18.2.
Not investment advice. Open the CBOE and CPRX stock pages for the full models.
Not investment advice.